Synergistic inhibitory actions of resveratrol, epigallocatechin-3-gallate, and diallyl trisulfide against skin cancer cell line A431 through mitochondrial caspase dependent pathway: a combinational drug approach.

MLA

Arumugam, Gobika, and Sangilimuthu Alagar Yadav. “Synergistic Inhibitory Actions of Resveratrol, Epigallocatechin-3-Gallate, and Diallyl Trisulfide against Skin Cancer Cell Line A431 through Mitochondrial Caspase Dependent Pathway: A Combinational Drug Approach.” Medical Oncology (Northwood, London, England), vol. 41, no. 3, Jan. 2024, p. 64. EBSCOhost, https://doi.org/10.1007/s12032-023-02292-3.

APA

Arumugam, G., & Alagar Yadav, S. (2024). Synergistic inhibitory actions of resveratrol, epigallocatechin-3-gallate, and diallyl trisulfide against skin cancer cell line A431 through mitochondrial caspase dependent pathway: a combinational drug approach. Medical Oncology (Northwood, London, England), 41(3), 64. https://doi.org/10.1007/s12032-023-02292-3

Chicago

Arumugam, Gobika, and Sangilimuthu Alagar Yadav. 2024. “Synergistic Inhibitory Actions of Resveratrol, Epigallocatechin-3-Gallate, and Diallyl Trisulfide against Skin Cancer Cell Line A431 through Mitochondrial Caspase Dependent Pathway: A Combinational Drug Approach.” Medical Oncology (Northwood, London, England) 41 (3): 64. doi:10.1007/s12032-023-02292-3.